The global AI in Life Science Analytics Market is anticipated to expand significantly, leveraging the transformative potential of artificial intelligence (AI) and machine learning technologies in healthcare. In 2023, the market was valued at approximately USD 1.7 billion and is expected to reach USD 4.31 billion by 2032, registering a robust compound annual growth rate (CAGR) of 10.9% during the forecast period from 2024 to 2032.
The global AI in Life Science Analytics Market is anticipated to expand significantly, leveraging the transformative potential of artificial intelligence (AI) and machine learning technologies in healthcare. In 2023, the market was valued at approximately USD 1.7 billion and is expected to reach USD 4.31 billion by 2032, registering a robust compound annual growth rate (CAGR) of 10.9% during the forecast period from 2024 to 2032.
AI in life sciences has revolutionized the analytics domain by enabling enhanced decision-making, streamlined clinical trials, and optimized drug discovery processes. The seamless integration of AI technologies is empowering stakeholders in the healthcare and pharmaceutical sectors to analyze complex datasets with greater precision, fostering personalized medicine development and innovative therapeutic strategies. Notable technological advancements, such as generative AI for structural protein prediction and natural language processing for data analysis, are further solidifying AI’s role in the life sciences ecosystem.
The market growth is bolstered by increased investments from pharmaceutical giants and global government initiatives to support AI-driven research and development. For instance, the U.S. National Artificial Intelligence Initiative Office (NAIIO) fosters innovation across academia, industry, and federal agencies. Meanwhile, initiatives in Europe and Asia Pacific emphasize using AI for cost efficiency, patient-centric healthcare, and advanced diagnostic techniques.
The impact of the COVID-19 pandemic has accelerated the adoption of AI-driven analytics. Disruptions in clinical trials and the urgent need for innovative solutions during the pandemic significantly spurred advancements in deep learning technologies and the development of AI applications tailored for healthcare.
Key regions such as North America and Europe dominate the market, attributed to their robust healthcare infrastructure, advanced technological adoption, and supportive regulatory frameworks. Emerging markets in Asia Pacific are poised for remarkable growth due to increasing investments in healthcare AI and the expanding presence of biotech companies in the region.
Prominent players such as IBM, IQVIA, and SAS Institute are focusing on launching advanced AI tools to improve patient outcomes and operational efficiency. Recent developments, such as AI-powered drug discovery platforms and data visualization tools, underline the industry's commitment to continuous innovation.
________________________________________
Major market players included in this report are:
1. IBM
2. IQVIA
3. SAS Institute, Inc.
4. Indegene
5. Lexalytics
6. Databricks
7. Sorcero
8. Axtria
9. Medidata Solutions
10. PathAI
11. NVIDIA
12. Merck KGaA
13. Fujitsu Limited
14. Evommune, Inc.
15. Accutar Biotechnology, Inc.
The detailed segments and sub-segments of the market are explained below:
By Delivery
AI in life sciences has revolutionized the analytics domain by enabling enhanced decision-making, streamlined clinical trials, and optimized drug discovery processes. The seamless integration of AI technologies is empowering stakeholders in the healthcare and pharmaceutical sectors to analyze complex datasets with greater precision, fostering personalized medicine development and innovative therapeutic strategies. Notable technological advancements, such as generative AI for structural protein prediction and natural language processing for data analysis, are further solidifying AI’s role in the life sciences ecosystem.
The market growth is bolstered by increased investments from pharmaceutical giants and global government initiatives to support AI-driven research and development. For instance, the U.S. National Artificial Intelligence Initiative Office (NAIIO) fosters innovation across academia, industry, and federal agencies. Meanwhile, initiatives in Europe and Asia Pacific emphasize using AI for cost efficiency, patient-centric healthcare, and advanced diagnostic techniques.
The impact of the COVID-19 pandemic has accelerated the adoption of AI-driven analytics. Disruptions in clinical trials and the urgent need for innovative solutions during the pandemic significantly spurred advancements in deep learning technologies and the development of AI applications tailored for healthcare.
Key regions such as North America and Europe dominate the market, attributed to their robust healthcare infrastructure, advanced technological adoption, and supportive regulatory frameworks. Emerging markets in Asia Pacific are poised for remarkable growth due to increasing investments in healthcare AI and the expanding presence of biotech companies in the region.
Prominent players such as IBM, IQVIA, and SAS Institute are focusing on launching advanced AI tools to improve patient outcomes and operational efficiency. Recent developments, such as AI-powered drug discovery platforms and data visualization tools, underline the industry's commitment to continuous innovation.
________________________________________
Major market players included in this report are:
1. IBM
2. IQVIA
3. SAS Institute, Inc.
4. Indegene
5. Lexalytics
6. Databricks
7. Sorcero
8. Axtria
9. Medidata Solutions
10. PathAI
11. NVIDIA
12. Merck KGaA
13. Fujitsu Limited
14. Evommune, Inc.
15. Accutar Biotechnology, Inc.
The detailed segments and sub-segments of the market are explained below:
By Delivery
- Cloud
- On-premise
- Software
- Hardware
- Services
- Research and Development
- Sales and Marketing Support
- Supply Chain Analytics
- Others
- Medical Devices
- Pharmaceutical
- Biotechnology
- Others
- North America: U.S., Canada, Mexico
- Europe: UK, Germany, France, Italy, Spain, Sweden, Denmark, Norway
- Asia Pacific: Japan, China, India, South Korea, Singapore, Australia, Thailand
- Latin America: Brazil, Argentina
- Middle East & Africa: South Africa, Saudi Arabia, UAE, Kuwait
- Historical year: 2022
- Base year: 2023
- Forecast period: 2024 to 2032
- Market estimates and forecasts for 10 years (2022-2032).
- Annualized revenues and regional-level analysis for each market segment.
- Detailed analysis of the geographical landscape with country-level data.
- Competitive insights into major players in the market.
- Strategic recommendations for market growth.
CHAPTER 1: GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET EXECUTIVE SUMMARY
1.1 Global AI in Life Science Analytics Market Size & Forecast (2022-2032)
1.2 Regional Summary
1.3 Segmental Summary
1.3.1 By Delivery
1.3.2 By Component
1.3.3 By Application
1.3.4 By End-Use
1.4 Key Trends
1.5 Recession Impact
1.6 Analyst Recommendation & Conclusion
CHAPTER 2: GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET DEFINITION AND RESEARCH ASSUMPTIONS
2.1 Research Objective
2.2 Market Definition
2.3 Research Assumptions
2.3.1 Inclusion & Exclusion
2.3.2 Limitations
2.4 Estimation Methodology
2.5 Years Considered for the Study
2.6 Currency Conversion Rates
CHAPTER 3: GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET DYNAMICS
3.1 Market Drivers
3.1.1 Advancements in AI Algorithms and Big Data Analytics
3.1.2 Government and Industry Initiatives
3.1.3 Increasing AI Applications in Drug Discovery and Diagnostics
3.2 Market Challenges
3.2.1 High Initial Costs and Skilled Workforce Requirements
3.2.2 Regulatory and Ethical Challenges
3.3 Market Opportunities
3.3.1 Expansion in Emerging Markets
3.3.2 Integration of Generative AI Technologies
CHAPTER 4: GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET INDUSTRY ANALYSIS
4.1 Porter’s Five Forces Model
4.1.1 Bargaining Power of Suppliers
4.1.2 Bargaining Power of Buyers
4.1.3 Threat of New Entrants
4.1.4 Threat of Substitutes
4.1.5 Competitive Rivalry
4.2 PESTEL Analysis
4.2.1 Political Factors
4.2.2 Economic Factors
4.2.3 Social Factors
4.2.4 Technological Factors
4.2.5 Environmental Factors
4.2.6 Legal Factors
4.3 Top Investment Opportunities
4.4 Top Winning Strategies
4.5 Disruptive Trends
4.6 Industry Expert Perspectives
CHAPTER 5: GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET SIZE & FORECASTS BY DELIVERY (2022-2032)
5.1 Segment Dashboard
5.2 Market Trends by Delivery
5.2.1 Cloud
5.2.2 On-premise
CHAPTER 6: GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET SIZE & FORECASTS BY COMPONENT (2022-2032)
6.1 Segment Dashboard
6.2 Market Trends by Component
6.2.1 Software
6.2.2 Hardware
6.2.3 Services
CHAPTER 7: GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET SIZE & FORECASTS BY APPLICATION (2022-2032)
7.1 Segment Dashboard
7.2 Market Trends by Application
7.2.1 Research and Development
7.2.2 Sales and Marketing Support
7.2.3 Supply Chain Analytics
7.2.4 Others
CHAPTER 8: GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET SIZE & FORECASTS BY END-USE (2022-2032)
8.1 Segment Dashboard
8.2 Market Trends by End-Use
8.2.1 Medical Devices
8.2.2 Pharmaceutical
8.2.3 Biotechnology
8.2.4 Others
CHAPTER 9: GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET SIZE & FORECASTS BY REGION (2022-2032)
9.1 North America
9.1.1 U.S.
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 UK
9.2.2 Germany
9.2.3 France
9.2.4 Italy
9.2.5 Spain
9.2.6 Sweden
9.2.7 Denmark
9.2.8 Norway
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 South Korea
9.3.5 Singapore
9.3.6 Australia
9.3.7 Thailand
9.4 Latin America
9.4.1 Brazil
9.4.2 Argentina
9.5 Middle East & Africa
9.5.1 South Africa
9.5.2 Saudi Arabia
9.5.3 UAE
9.5.4 Kuwait
CHAPTER 10: COMPETITIVE INTELLIGENCE
10.1 Key Company SWOT Analysis
10.1.1 IBM
10.1.2 IQVIA
10.1.3 SAS Institute, Inc.
10.2 Top Market Strategies
10.3 Company Profiles
CHAPTER 11: RESEARCH PROCESS
11.1 Research Process
11.1.1 Data Mining
11.1.2 Analysis
11.1.3 Market Estimation
11.1.4 Validation
11.1.5 Publishing
11.2 Research Attributes
12. LIST OF TABLES
TABLE 1. Global AI in Life Science Analytics Market, Report Scope
TABLE 2. Market Estimates & Forecasts by Delivery, 2022-2032 (USD Million)
TABLE 3. Market Estimates & Forecasts by Component, 2022-2032 (USD Million)
TABLE 4. Market Estimates & Forecasts by Application, 2022-2032 (USD Million)
TABLE 5. Market Estimates & Forecasts by End-Use, 2022-2032 (USD Million)
TABLE 6. Regional Market Estimates & Forecasts, 2022-2032 (USD Million)
...
This list is not complete; the final report contains more than 100 tables. The list may be updated in the final deliverable.
12. LIST OF FIGURES
FIGURE 1. Global AI in Life Science Analytics Market, Research Methodology
FIGURE 2. Global Market Estimation Techniques
FIGURE 3. Key Market Trends in AI and Life Science Analytics
FIGURE 4. Porter’s Five Forces Analysis
FIGURE 5. PESTEL Analysis of the AI in Life Science Analytics Market
FIGURE 6. Regional Market Snapshot, 2022 & 2032
...
This list is not complete; the final report contains more than 50 figures. The list may be updated in the final deliverable.
1.1 Global AI in Life Science Analytics Market Size & Forecast (2022-2032)
1.2 Regional Summary
1.3 Segmental Summary
1.3.1 By Delivery
1.3.2 By Component
1.3.3 By Application
1.3.4 By End-Use
1.4 Key Trends
1.5 Recession Impact
1.6 Analyst Recommendation & Conclusion
CHAPTER 2: GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET DEFINITION AND RESEARCH ASSUMPTIONS
2.1 Research Objective
2.2 Market Definition
2.3 Research Assumptions
2.3.1 Inclusion & Exclusion
2.3.2 Limitations
2.4 Estimation Methodology
2.5 Years Considered for the Study
2.6 Currency Conversion Rates
CHAPTER 3: GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET DYNAMICS
3.1 Market Drivers
3.1.1 Advancements in AI Algorithms and Big Data Analytics
3.1.2 Government and Industry Initiatives
3.1.3 Increasing AI Applications in Drug Discovery and Diagnostics
3.2 Market Challenges
3.2.1 High Initial Costs and Skilled Workforce Requirements
3.2.2 Regulatory and Ethical Challenges
3.3 Market Opportunities
3.3.1 Expansion in Emerging Markets
3.3.2 Integration of Generative AI Technologies
CHAPTER 4: GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET INDUSTRY ANALYSIS
4.1 Porter’s Five Forces Model
4.1.1 Bargaining Power of Suppliers
4.1.2 Bargaining Power of Buyers
4.1.3 Threat of New Entrants
4.1.4 Threat of Substitutes
4.1.5 Competitive Rivalry
4.2 PESTEL Analysis
4.2.1 Political Factors
4.2.2 Economic Factors
4.2.3 Social Factors
4.2.4 Technological Factors
4.2.5 Environmental Factors
4.2.6 Legal Factors
4.3 Top Investment Opportunities
4.4 Top Winning Strategies
4.5 Disruptive Trends
4.6 Industry Expert Perspectives
CHAPTER 5: GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET SIZE & FORECASTS BY DELIVERY (2022-2032)
5.1 Segment Dashboard
5.2 Market Trends by Delivery
5.2.1 Cloud
5.2.2 On-premise
CHAPTER 6: GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET SIZE & FORECASTS BY COMPONENT (2022-2032)
6.1 Segment Dashboard
6.2 Market Trends by Component
6.2.1 Software
6.2.2 Hardware
6.2.3 Services
CHAPTER 7: GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET SIZE & FORECASTS BY APPLICATION (2022-2032)
7.1 Segment Dashboard
7.2 Market Trends by Application
7.2.1 Research and Development
7.2.2 Sales and Marketing Support
7.2.3 Supply Chain Analytics
7.2.4 Others
CHAPTER 8: GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET SIZE & FORECASTS BY END-USE (2022-2032)
8.1 Segment Dashboard
8.2 Market Trends by End-Use
8.2.1 Medical Devices
8.2.2 Pharmaceutical
8.2.3 Biotechnology
8.2.4 Others
CHAPTER 9: GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET SIZE & FORECASTS BY REGION (2022-2032)
9.1 North America
9.1.1 U.S.
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 UK
9.2.2 Germany
9.2.3 France
9.2.4 Italy
9.2.5 Spain
9.2.6 Sweden
9.2.7 Denmark
9.2.8 Norway
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 South Korea
9.3.5 Singapore
9.3.6 Australia
9.3.7 Thailand
9.4 Latin America
9.4.1 Brazil
9.4.2 Argentina
9.5 Middle East & Africa
9.5.1 South Africa
9.5.2 Saudi Arabia
9.5.3 UAE
9.5.4 Kuwait
CHAPTER 10: COMPETITIVE INTELLIGENCE
10.1 Key Company SWOT Analysis
10.1.1 IBM
10.1.2 IQVIA
10.1.3 SAS Institute, Inc.
10.2 Top Market Strategies
10.3 Company Profiles
CHAPTER 11: RESEARCH PROCESS
11.1 Research Process
11.1.1 Data Mining
11.1.2 Analysis
11.1.3 Market Estimation
11.1.4 Validation
11.1.5 Publishing
11.2 Research Attributes
12. LIST OF TABLES
TABLE 1. Global AI in Life Science Analytics Market, Report Scope
TABLE 2. Market Estimates & Forecasts by Delivery, 2022-2032 (USD Million)
TABLE 3. Market Estimates & Forecasts by Component, 2022-2032 (USD Million)
TABLE 4. Market Estimates & Forecasts by Application, 2022-2032 (USD Million)
TABLE 5. Market Estimates & Forecasts by End-Use, 2022-2032 (USD Million)
TABLE 6. Regional Market Estimates & Forecasts, 2022-2032 (USD Million)
...
This list is not complete; the final report contains more than 100 tables. The list may be updated in the final deliverable.
12. LIST OF FIGURES
FIGURE 1. Global AI in Life Science Analytics Market, Research Methodology
FIGURE 2. Global Market Estimation Techniques
FIGURE 3. Key Market Trends in AI and Life Science Analytics
FIGURE 4. Porter’s Five Forces Analysis
FIGURE 5. PESTEL Analysis of the AI in Life Science Analytics Market
FIGURE 6. Regional Market Snapshot, 2022 & 2032
...
This list is not complete; the final report contains more than 50 figures. The list may be updated in the final deliverable.
